Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corman

Showing results (831-840 of 841) with videos related to

Pageof 85
Sort By:
Cell|October 15, 2020
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster ModelJakob Kreye, S Momsen Reincke, Hans-Christian Kornau, et al.
Ebiomedicine|December 27, 2021
Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: A multi-centre clinical evaluationLisa J Krüger, Amilcar Tanuri, Andreas K Lindner, et al.
The European Respiratory Journal|June 21, 2022
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophagesKatja Hönzke, Benedikt Obermayer, Christin Mache, et al.
Cell|January 15, 2022
Complement activation induces excessive T cell cytotoxicity in severe COVID-19Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
The Lancet. Infectious Diseases|February 23, 2025
Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational studyLouella M R Kasbergen, Erwin de Bruin, Felicity Chandler, et al.
The Lancet. Infectious Diseases|February 23, 2025
Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational studyLouise Sigfrid, Xin Hui S Chan, Louella M R Kasbergen, et al.
Viruses|January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 LaboratoriesPolina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Cell|August 19, 2020
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentJonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
Eclinicalmedicine|September 7, 2021
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01January Weiner, Phillip Suwalski, Manuel Holtgrewe, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2010
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative studyAdrian F Daly, Maria A Tichomirowa, Patrick Petrossians, et al.
Pageof 85

Showing results (831-840 of 841) with videos related to

Sort By:
Pageof 85
Cell|October 15, 2020
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster ModelJakob Kreye, S Momsen Reincke, Hans-Christian Kornau, et al.
Ebiomedicine|December 27, 2021
Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: A multi-centre clinical evaluationLisa J Krüger, Amilcar Tanuri, Andreas K Lindner, et al.
The European Respiratory Journal|June 21, 2022
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophagesKatja Hönzke, Benedikt Obermayer, Christin Mache, et al.
Cell|January 15, 2022
Complement activation induces excessive T cell cytotoxicity in severe COVID-19Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
The Lancet. Infectious Diseases|February 23, 2025
Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational studyLouella M R Kasbergen, Erwin de Bruin, Felicity Chandler, et al.
The Lancet. Infectious Diseases|February 23, 2025
Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational studyLouise Sigfrid, Xin Hui S Chan, Louella M R Kasbergen, et al.
Viruses|January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 LaboratoriesPolina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Cell|August 19, 2020
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentJonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
Eclinicalmedicine|September 7, 2021
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01January Weiner, Phillip Suwalski, Manuel Holtgrewe, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2010
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative studyAdrian F Daly, Maria A Tichomirowa, Patrick Petrossians, et al.
Pageof 85